RM
+
Illustration showing repaglinide (yellow white blue and red spheres centre-left and centre-right) binding to an ATP-dependent potassium channel (mu
RM
+
Illustration showing repaglinide (yellow red and white spheres centre-left and centre-right) binding to an ATP-dependent potassium channel (multicol
RM
+
Illustration showing repaglinide (yellow white blue and red spheres centre-left and centre-right) binding to an ATP-dependent potassium channel (mu
RM
+
Illustration showing repaglinide (yellow white blue and red spheres within pink structures) binding to ATP-dependent potassium channel (multicoloure
RM
+
Illustration of tirzepatide (red blue and grey spheres) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (pinkbeige vertical) A G
RM
+
Illustration of tirzepatide (silver helix) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (multi-coloured helices across membrane)
RM
+
SpCas9 enzymes splicing DNA illustration
RM
+
SpCas9 enzymes splicing DNA illustration
RM
+
SpCas9 enzymes splicing DNA illustration
ED
+
Train passengers are seen on escalators at the station in Saitama north of Tokyo Japan on October 1 2021 Saitama Prefecture starts non-binding loc
RF
+
Illustration of a bispecific antibody showing two discrete antigen binding sites (pink and green) within the antibody structure by THOM LEACH SCIE
RF
+
Illustration of a bispecific antibody (yellow and orange) binding to two different membrane proteins (purple and blue) by THOM LEACH SCIENCE PHOTO
RF
+
Illustration of a bispecific antibody (pink and green) binding to two different membrane proteins (yellow and blue) by THOM LEACH SCIENCE PHOTO LI
RF
+
Illustration of a bispecific antibody (green and light blue) binding to two different membrane proteins (pink and dark blue) by THOM LEACH SCIENCE
RF
+
Illustration of a bispecific antibody (blue and purple) binding to two different membrane proteins (green and orange) by THOM LEACH SCIENCE PHOTO
RF
+
Illustration of a bispecific antibody showing two discrete antigen binding sites (pink and green) within the antibody structure by THOM LEACH SCI
RF
+
Illustration of an aptamer drug Aptamers are a special class of nucleic acids that can bind proteins or other cellular targets and are potential drug
RF
+
Illustration of an aptamer drug Aptamers are a special class of nucleic acids that can bind proteins or other cellular targets and are potential drug
RF
+
Illustration of an aptamer drug Aptamers are a special class of nucleic acids that can bind proteins or other cellular targets and are potential drug
ED
+
Train passengers are seen on escalators at the station in Saitama north of Tokyo Japan on October 1 2021 Saitama Prefecture starts non-binding loc
RF
+
Illustration of an aptamer drug Aptamers are a special class of nucleic acids that can bind proteins or other cellular targets and are potential drug
RF
+
Illustration of a thrombin-RNA (ribonucleic acid) aptamer complex Aptamers are a special class of nucleic acids that can bind proteins or other cellu
RF
+
Illustration of an aptamer drug Aptamers are a special class of nucleic acids that can bind proteins or other cellular targets and are potential drug
RF
+
Illustration of an aptamer drug Aptamers are a special class of nucleic acids that can bind proteins or other cellular targets and are potential drug
RF
+
Illustration of an aptamer drug Aptamers are a special class of nucleic acids that can bind proteins or other cellular targets and are potential drug
RF
+
Illustration of an aptamer drug Aptamers are a special class of nucleic acids that can bind proteins or other cellular targets and are potential drug
RF
+
Illustration of an aptamer drug Aptamers are a special class of nucleic acids that can bind proteins or other cellular targets and are potential drug
RF
+
Illustration of an aptamer drug Aptamers are a special class of nucleic acids that can bind proteins or other cellular targets and are potential drug
RF
+
Illustration of antibody drug conjugates Antibody drug conjugates can consist of a monoclonal antibody (blue) and a cytotoxic payload (orange) for ta
ED
+
Train passengers are seen on escalators at the station in Saitama north of Tokyo Japan on October 1 2021 Saitama Prefecture starts non-binding loc
RF
+
Illustration of antibody drug conjugates Antibody drug conjugates can consist of a monoclonal antibody (bluepurple) and a cytotoxic payload (orange)
RF
+
Illustration of antibody drug conjugates Antibody drug conjugates can consist of a monoclonal antibody (bluepurple) and a cytotoxic payload (glowing
RF
+
Illustration of antibody drug conjugates Antibody drug conjugates can consist of a monoclonal antibody (bluepurple) and a cytotoxic payload (orange)
RF
+
Illustration of the antigen binding site (orange) of a human IgG1 (immunoglobulin G1) antibody by THOM LEACH SCIENCE PHOTO LIBRARY
RF
+
original cellars of Palo Ripoll by ZoonarBartomeu Bala
RF
+
Taubenheim in upper lusatia by ZoonarKarin Jähne
RF
+
Upper Lusatian house by ZoonarKarin Jähne
RF
+
Upper Lusatian house by ZoonarKarin Jähne
RF
+
Taubenheim in upper lusatia in saxon by ZoonarKarin Jähne
ED
+
Train passengers are seen on escalators at the station in Saitama north of Tokyo Japan on October 1 2021 Saitama Prefecture starts non-binding loc
RF
+
Taubenheim in upper lusatia by ZoonarKarin Jähne
RF
+
Taubenheim in upper lusatia by ZoonarKarin Jähne
RF
+
Taubenheim in upper lusatia by ZoonarKarin Jähne
RF
+
Taubenheim in upper lusatia by ZoonarKarin Jähne
RF
+
Taubenheim in upper lusatia by ZoonarKarin Jähne
RM
+
Antibodies attacking virus particle illustration
RM
+
Antibodies attacking virus particle illustration
RM
+
Antibodies attacking virus particles illustration
RM
+
Metformin antidiabetic drug action illustration
ED
+
Train passengers are seen on escalators at the station in Saitama north of Tokyo Japan on October 1 2021 Saitama Prefecture starts non-binding loc
RM
+
Metformin antidiabetic drug action illustration
RM
+
Illustration showing repaglinide (white blue and red spheres within helices) binding to an ATP-dependent potassium channel (multicoloured helices) on
RM
+
Antidiabetic drug tirzepatide molecular structure illustration
RM
+
Antidiabetic drug tirzepatide molecular structure illustration
RM
+
Illustration showing the molecular structure of tirzepatide a drug used to treat type 2 diabetes and obesity It functions by mimicking glucose-depen
RM
+
Illustration showing the molecular structure of tirzepatide a drug used to treat type 2 diabetes and obesity It functions by mimicking glucose-depen
RM
+
Illustration of the molecular structure of semaglutide a drug used to treat type-2 diabetes Semaglutide is a GLP-1 agonist meaning it mimics the fu
RM
+
Illustration of the molecular structure of semaglutide a drug used to treat type-2 diabetes Semaglutide is a GLP-1 agonist meaning it mimics the fu
RM
+
Antidiabetic drug semaglutide molecular structure illustration
ED
+
Train passengers are seen on escalators at the station in Saitama north of Tokyo Japan on October 1 2021 Saitama Prefecture starts non-binding loc
RM
+
Antidiabetic drug semaglutide molecular structure illustration
RM
+
Illustration of tirzepatide (red blue and grey spheres) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (beige vertical) A G prot
RM
+
Illustration of tirzepatide (silver helix) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (multi-coloured helices across membrane)
RM
+
Illustration of tirzepatide (red blue and grey spheres) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (multi-coloured 3d structur
RM
+
Illustration of tirzepatide (silver helix) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (multi-coloured helices across membrane)
RM
+
Illustration of tirzepatide (red blue and grey spheres) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (beige vertical structure)
RM
+
Illustration of semaglutide (blue red and grey spheres) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (multi-coloured 3D structur
RM
+
Semaglutide antidiabetic drug action illustration
RF
+
Zona binding assay This test evaluates the ability of sperm to bind to the outer layer of the egg known as the zona pellucida by WLADIMIR BULGARS
ED
+
Train passengers are seen on escalators at the station in Saitama north of Tokyo Japan on October 1 2021 Saitama Prefecture starts non-binding loc
RF
+
Sperm hyaluronan-binding assay (HBA) This test measures the ability of sperm to bind to hyaluronan a substance found in the follicular fluid surroun
RF
+
Sperm function test This test measures the ability of the sperm to perform specific functions necessary for fertilization such as binding to an egg
RF
+
DNA replication illustration by ALI DAMOUHSCIENCE PHOTO LIBRARY
RF
+
DNA replication illustration by ALI DAMOUHSCIENCE PHOTO LIBRARY
RM
+
Chimeric antigen receptor illustration CAR T cells are currently developed with the hope they may eventually transform immunotherapy of cancer patie
RM
+
Chimeric antigen receptor illustration CAR T cells are currently developed with the hope they may eventually transform immunotherapy of cancer patie
RM
+
Chimeric antigen receptor illustration CAR T cells are currently developed with the hope they may eventually transform immunotherapy of cancer patie
RM
+
Chimeric antigen receptor illustration CAR T cells are currently developed with the hope they may eventually transform immunotherapy of cancer patie
RM
+
Chimeric antigen receptor illustration CAR T cells are currently developed with the hope they may eventually transform immunotherapy of cancer patie
ED
+
Train passengers are seen on escalators at the station in Saitama north of Tokyo Japan on October 1 2021 Saitama Prefecture starts non-binding loc
RM
+
Chimeric antigen receptor illustration CAR T cells are currently developed with the hope they may eventually transform immunotherapy of cancer patie
RM
+
Chimeric antigen receptor illustration CAR T cells are currently developed with the hope they may eventually transform immunotherapy of cancer patie
RF
+
Illustration showing the upper half of a man with transparent skin revealing the lungs affected by Covid-19 pneumonia and close-up of SARS-CoV-2 vir
RF
+
Adalimumab binding tumour necrosis factor-alpha illustration
RF
+
Adalimumab binding tumour necrosis factor-alpha illustration
RF
+
Adalimumab binding tumour necrosis factor-alpha illustration
RF
+
Adalimumab binding tumour necrosis factor-alpha illustration
RF
+
Adalimumab binding tumour necrosis factor-alpha illustration
RF
+
Adalimumab binding tumour necrosis factor-alpha illustration
ED
+
Train passengers are seen on escalators at the station in Saitama north of Tokyo Japan on October 1 2021 Saitama Prefecture starts non-binding loc
RF
+
Nanobodies and Covid-19 virus spike protein illustration
RF
+
Young athlete snowboarder sitting in deep snow Braov Braov Romania by Cavan Images Buduleanu Emanuel Andrei
RF
+
Snowboarder riding in deep snow and spraying powder Braov Braov Romania by Cavan Images Buduleanu Emanuel Andrei
RF
+
Snowboarder riding in deep snow and spraying powder Braov Braov Romania by Cavan Images Buduleanu Emanuel Andrei
RF
+
Happy athlete snowboarder covered in snow Braov Braov Romania by Cavan Images Buduleanu Emanuel Andrei
RF
+
Snowboarder riding fast on snow freeride slope Braov Braov Romania by Cavan Images Buduleanu Emanuel Andrei
RF
+
Snowboarder riding fast on snow freeride slope Braov Braov Romania by Cavan Images Buduleanu Emanuel Andrei
RF
+
Saxon by ZoonarKarin Jaehne
RF
+
GLP-1 receptors and semaglutide agonists illustration
ED
+
Train passengers are seen on escalators at the station in Saitama north of Tokyo Japan on October 1 2021 Saitama Prefecture starts non-binding loc
2485
0
https://www.afloimages.com/search/binding.html